Robbins LLP is Investigating the Officers and Directors of Morphic Holding, Inc. (MORF)

Robbins LLP is investigating Morphic Holding, Inc. (NADSAQ: MORF) to determine whether certain Morphic Holding officers and directors violated securities laws and breached fiduciary duties to shareholders.  Mophic Holding is a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer.

What Now: Morphic Holding, Inc. shareholders have legal options.  If you own shares of Morphic Holding, Inc. and have lost money in your investment, contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.